Clinical Trial Update: Renal Sympathetic Denervation Combined With Aorticorenal Ganglion Ablation for Treatment of Hypertension [NA]

View source ↗

Summary

A clinical trial evaluating renal sympathetic denervation combined with aorticorenal ganglion ablation for hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Aorticorenal Ganglion, Renal Sympathetic Denervation | NA | Status: WITHDRAWN